Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Proteostasis Therapeutics Reports Positive Results from European Cystic Fibrosis Research

Proteostasis Therapeutics' shares traded higher today after the company reported positive results in its European Cystic Fibrosis study of organoids grown from human stem cells. The firm believes the ongoing ex-vivo study supports initiation of a human clinical trial in mid-20...

Silver's Sharp Reaction Back

Technical analyst Clive Maund charts silver and explains why he believes it hasn't hit a final top. Silver reacted back sharply on Thursday and Friday after a parabolic blowoff top. This was not a final top, but it does indicate that silver needs to take a rest and co...

Coronavirus Propels Telemedicine into the Spotlight

Summary: Coronavirus could be the game changer that propels telemedicine into the mainstream. Virtual clinical services have been around since the '90s but had failed to catch on. Now, a concerted effort by healthcare providers, insurance companies, the federal government...

Assembly Biosciences Stock Sizzles Following Phase 2a Announcement and Buy Rating from Mizuho

Good news is piling up for this healthcare stock engaged in the treatment of hepatitis B as it trades at 5X its average volume with a 30% stock price gain over previous close. Assembly Biosciences Inc (ASMB:NASDAQ) announced in a press release on October 16, 2019, ...

Buzz on the Bullboards: Sell in May and go away?

As investors assess the strategy of liquidating positions before the summer, lingering concerns over an impending economic recession haven’t appeared to slow down activity on the Bullboards. Instead, as we approach zero hour on the deadline to settle t...

Nov 21st 2019, Silver Chartbook: Sentiment silence and lies

Sentiment, silence and lies We spoke in our last silver chartbook about how to take a contrarian position. As well we explained how to bet against consensus. Sentiment is one aspect supporting a contrarian trader. This is obviously necessary to achieve a “buy low, sell ...

Once in a Blue Moon Short/Put Set Up

echnical analyst Clive Maund charted the S&P 500 and saw a "perfect shorting set-up." Note: This article was originally published on July 31 before the Fed's rate announcement. The charts we will look at in this update suggest that this is a perfect shor...

Technical Analyst Profiles a 'Promising Copper & Gold Stock'

Technical analyst Clive Maund charts this copper and gold stock that is exploring a project in British Columbia that he rates an "immediate buy." Libero Copper and Gold Corp. (LBC:TSX.V:, LBCMF:OTCQB) is looking attractive here. The fundamentals for the company are b...

Energy Stock Is 'Looking to Break Out of Large Base'

Technical analyst Clive Maund explains why he believes this company with projects in Thailand and Indonesia is about ready to start another upleg. Pan Orient Energy Corp. (POE:TSX.V) presents an overall positive picture of a stock that is probably on the verge of break...

Junior Gold Stock 'On the Up'

Technical analyst Clive Maund charts a junior explorer and explains why he sees it as a speculative buy. Although we are generally aiming to gravitate towards the large and mid-cap gold stocks during the early stages of the sector bull market, it is worth considering ...
1 2 3 4 5 6 7 8 9 10 ...